HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul N Newton Selected Research

Mefloquine (Lariam)

1/2020Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
12/2010A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos.
7/2010An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
10/2004Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul N Newton Research Topics

Disease

44Malaria
01/2023 - 01/2003
36Infections
01/2023 - 10/2005
32Falciparum Malaria (Plasmodium falciparum Malaria)
12/2020 - 04/2002
18Scrub Typhus (Typhus, Scrub)
12/2023 - 02/2008
16Dengue (Dengue Fever)
11/2022 - 04/2006
14Fever (Fevers)
01/2023 - 09/2003
8Endemic Flea-Borne Typhus (Typhus, Endemic Flea Borne)
01/2020 - 05/2009
7Melioidosis
02/2024 - 03/2003
7Central Nervous System Infections (Central Nervous System Infection)
12/2019 - 08/2011
5Typhoid Fever (Typhoid)
01/2020 - 06/2005
4Leptospirosis
02/2024 - 07/2010
4Japanese Encephalitis
01/2023 - 12/2015
4Body Weight (Weight, Body)
07/2014 - 04/2005
3Communicable Diseases (Infectious Diseases)
02/2024 - 02/2014
3Epidemic Louse-Borne Typhus (Typhus)
12/2023 - 02/2008
3Coma (Comas)
01/2022 - 07/2003
3Bacterial Infections (Bacterial Infection)
01/2022 - 11/2015
3Beriberi
12/2020 - 02/2011
3Bacteremia
01/2020 - 01/2013
3Sepsis (Septicemia)
01/2020 - 09/2003
3Jaundice (Icterus)
01/2015 - 08/2009
2COVID-19
11/2023 - 01/2020
2Pneumococcal Infections
01/2022 - 12/2019
2Pneumonia (Pneumonitis)
01/2022 - 09/2020
2Abscess
01/2020 - 08/2017
2Vivax Malaria
01/2020 - 01/2019
2Acute Febrile Encephalopathy
03/2019 - 07/2012
2Meningitis
12/2017 - 07/2012
2Inflammation (Inflammations)
01/2016 - 01/2015
2Reinfection
01/2016 - 10/2004
2Virus Diseases (Viral Diseases)
01/2016 - 11/2015
2Acute malaria
01/2015 - 12/2003
2Cryptococcal Meningitis
12/2012 - 09/2002
2Hepatitis
07/2010 - 08/2009
2Heart Failure
11/2007 - 09/2003
1Seizures (Absence Seizure)
12/2022
1Meningoencephalitis
10/2022
1Autoimmune Diseases of the Nervous System
10/2022
1Tuberculosis (Tuberculoses)
01/2022
1Hypoxia (Hypoxemia)
09/2020
1Vomiting
01/2020
1Hemolysis
01/2019
1Glucosephosphate Dehydrogenase Deficiency
01/2019

Drug/Important Bio-Agent (IBA)

23Immunoglobulin M (IgM)IBA
02/2024 - 04/2006
23Antimalarials (Antimalarial Agents)IBA
11/2020 - 04/2002
22Anti-Bacterial Agents (Antibiotics)IBA
02/2024 - 06/2005
17artemisinin (artemisinine)IBA
01/2022 - 02/2008
16ArtesunateIBA
03/2015 - 04/2002
14AntigensIBA
02/2024 - 03/2004
13Immunoglobulin G (IgG)IBA
12/2023 - 04/2006
13AntibodiesIBA
01/2023 - 04/2006
11EnzymesIBA
12/2023 - 08/2005
10ImmunosorbentsIBA
12/2023 - 08/2005
8artenimol (dihydroartemisinin)IBA
01/2020 - 04/2002
8Doxycycline (Periostat)FDA LinkGeneric
01/2020 - 04/2005
6VaccinesIBA
11/2023 - 06/2013
6Thiamine (Aneurin)FDA Link
12/2020 - 09/2003
6piperaquineIBA
01/2020 - 07/2010
6Biomarkers (Surrogate Marker)IBA
11/2019 - 02/2011
6Chloroquine (Aralen)FDA LinkGeneric
06/2012 - 05/2003
5Conjugate VaccinesIBA
01/2022 - 01/2020
5Lumefantrine Drug Combination Artemether (Coartem)FDA Link
01/2020 - 10/2004
5RNA (Ribonucleic Acid)IBA
12/2019 - 01/2016
5Quinine (Quinson)FDA Link
10/2014 - 07/2003
5TabletsIBA
07/2014 - 01/2003
4Proteins (Proteins, Gene)FDA Link
01/2023 - 09/2012
4TransketolaseIBA
12/2020 - 03/2007
4PrimaquineFDA Link
01/2020 - 11/2018
4Mefloquine (Lariam)FDA LinkGeneric
01/2020 - 10/2004
3FluoroquinolonesIBA
01/2020 - 04/2010
3Chloramphenicol (Chloromycetin)FDA Link
01/2019 - 06/2005
3ArtemetherFDA Link
01/2018 - 12/2003
3pyrimethamine drug combination fanasil (Fansidar)FDA Link
10/2004 - 05/2003
2Oxygen (Dioxygen)IBA
01/2022 - 09/2020
2Viral RNAIBA
03/2019 - 01/2016
2Azithromycin (Zithromax)FDA LinkGeneric
01/2019 - 01/2018
2SoilIBA
01/2018 - 01/2011
2C-Reactive ProteinIBA
01/2016 - 11/2015
2ArtemisininsIBA
11/2013 - 08/2011
2Lactic Acid (Lactate)FDA LinkGeneric
02/2009 - 07/2003
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
11/2007 - 04/2006
2Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
10/2005 - 10/2005
1Polysaccharides (Glycans)IBA
02/2024
1ProteomeIBA
01/2023
1Malaria VaccinesIBA
01/2023
1Counterfeit DrugsIBA
12/2022
1Environmental DNAIBA
12/2022
1Complement System Proteins (Complement)IBA
12/2022
1AutoantibodiesIBA
10/2022
1Diphosphates (Pyrophosphates)IBA
12/2020
11- eicosanoyl- 3''- N- (trifluoroacetyl)kanamycin (ETKA)IBA
12/2020
18-aminoquinolineIBA
01/2020
1Amodiaquine (Camoquin)FDA Link
01/2020
1beta-Lactamases (beta-Lactamase)IBA
01/2020
1Peptides (Polypeptides)IBA
11/2019
1mesoglycanIBA
11/2019
1tafenoquineIBA
01/2019

Therapy/Procedure

19Therapeutics
01/2020 - 10/2003
6Mass Drug Administration
08/2021 - 01/2018
2Insecticide-Treated Bednets
11/2018 - 02/2013